5% GLH8NDE

DRUG2 trials

Sponsors

GL Pharm Tech Corporation

Conditions

Dry Eye Syndromes

Phase 1

A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers

CompletedNCT04104997

GL Pharm Tech CorporationDry Eye Syndromes

Start: 2019-09-26End: 2020-07-17Updated: 2020-12-19

Phase 2

Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease

GL Pharm Tech CorporationDry Eye Syndromes

Start: 2021-04-01End: 2022-04-30Target: 99Updated: 2021-01-06